Adcock loses AIDS business to Aspen; Meda snaps up GSK consumer products;

@FiercePharma: Merck KGaA taps new pharma chief for its pharma ops Article | Follow @FiercePharma

> Adcock Ingram, Africa's largest over-the-counter drug company, shares fell after rival Aspen Pharmacare got a bigger portion of a 4.16 billion-rand ($610 million) contract to supply AIDS treatments. News

> Arthritis patients taking opioid pain drugs had a higher risk of bone fractures and death compared with people taking other painkillers, according to a study that looked at Medicare claims records. Item

> Japan's Otsuka Holdings (4578.T) could rise about 5 percent on its market debut Wednesday after pricing its $2.4 billion IPO conservatively to reflect investor worries about its heavy reliance on profits from one drug. Report

> Ahmedabad, India-based Lincoln Pharmaceuticals (LPL), has tied up with U.S.-based Human Biosciences (HBI) for exclusive marketing and distribution of two of HBI's wound care management products in India. Item

> Meda bought three over-the-counter drug products from GlaxoSmithKline for about $34 million. Story

> Momenta Pharmaceuticals said it has completed its underwritten public offering of 4 million shares of its common stock, offered at a price of $14.35 per share. Story

> Hungarian drugmaker Richter has signed a long-term biosimilars license and collaboration agreement with Japanese group Mochida Pharmaceutical. Report

> Certain women who take estrogen alone, without progestin, to treat menopause symptoms may actually be protected from breast cancer. Article 

Biotech News

 @FierceBiotech: Lab tech firm rounds up $17M in Series B cash. News | Follow @FierceBiotech

 @JohnCFierce: Lilly suspended late-stage tasisulam trial after recording a dozen patient deaths. 3 setbacks in 3 months. Report  | Follow @JohnCFierce

> Lilly dealt another blow as investigators suspend Ph3 melanoma trial. Article

> Zerhouni replaces Cluzel as Sanofi R&D czar. News

Biotech Research News

> New stem cell strategy cures diabetes in mice. Story

> DoD awards $1.3M grant to develop artificial blood. Item

> Cell transplant gets paralyzed monkey back on his feet. Story

> NASA stokes fiery debate over bacterium study. Article

> Investigators use microthread to stitch cells into place. Report

Manufacturing News

> J&J/McNeil plays contractor card in Rolaids recall. Report

> Freezing DTap vax has unintended effect. News

> In turnabout, India to send inspectors overseas. Article

> Shortages highlight supply chain communications problem. Item

And finally ... In addition to being good for the heart, high levels of so-called "good" cholesterol may protect against Alzheimer's disease, U.S. researchers said. Report

Suggested Articles

Astellas and Seattle Genetics are out with Padcev-Keytruda combo data that may be good enough to snag an expedited regulatory review, analysts say.

Distributors had offered billions of dollars to wrap up opioid litigation, but that effort has suffered a major setback, WSJ reports.

While no shortages of drug supplies have been reported, governments are trying to get a handle on what they can do if they materialize.